142 related articles for article (PubMed ID: 31678380)
41. Stable perfluorocarbon emulsions for the delivery of halogenated ether anesthetics.
Ashrafi B; Tootoonchi MH; Bardsley R; Molano RD; Ruiz P; Pretto EA; Fraker CA
Colloids Surf B Biointerfaces; 2018 Dec; 172():797-805. PubMed ID: 30342412
[TBL] [Abstract][Full Text] [Related]
42. Design and evaluation of theranostic perfluorocarbon particles for simultaneous antigen-loading and ¹⁹F-MRI tracking of dendritic cells.
Dewitte H; Geers B; Liang S; Himmelreich U; Demeester J; De Smedt SC; Lentacker I
J Control Release; 2013 Jul; 169(1-2):141-9. PubMed ID: 23567042
[TBL] [Abstract][Full Text] [Related]
43. Quantitative (1)H MRI, (19)F MRI, and (19)F MRS of cell-internalized perfluorocarbon paramagnetic nanoparticles.
Kok MB; de Vries A; Abdurrachim D; Prompers JJ; Grüll H; Nicolay K; Strijkers GJ
Contrast Media Mol Imaging; 2011; 6(1):19-27. PubMed ID: 20648660
[TBL] [Abstract][Full Text] [Related]
44. Investigations on the transfer of porphyrin from o/w emulsion droplets to liposomes with two different methods.
Dawoud M
Drug Dev Ind Pharm; 2015 Jan; 41(1):156-62. PubMed ID: 24164468
[TBL] [Abstract][Full Text] [Related]
45. 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons.
Partlow KC; Chen J; Brant JA; Neubauer AM; Meyerrose TE; Creer MH; Nolta JA; Caruthers SD; Lanza GM; Wickline SA
FASEB J; 2007 Jun; 21(8):1647-54. PubMed ID: 17284484
[TBL] [Abstract][Full Text] [Related]
46. Folate-conjugated near-infrared fluorescent perfluorocarbon nanoemulsions as theranostics for activated macrophage COX-2 inhibition.
Vichare R; Crelli C; Liu L; McCallin R; Cowan A; Stratimirovic S; Herneisey M; Pollock JA; Janjic JM
Sci Rep; 2023 Sep; 13(1):15229. PubMed ID: 37709807
[TBL] [Abstract][Full Text] [Related]
47. Therapeutic oxygen delivery by perfluorocarbon-based colloids.
Krafft MP; Riess JG
Adv Colloid Interface Sci; 2021 Aug; 294():102407. PubMed ID: 34120037
[TBL] [Abstract][Full Text] [Related]
48. Perfluorocarbon species and nebulizer type influence aerosolization rate and particle size of perfluorocarbon aerosol.
Rüdiger M; Gregor T; Burkhardt W; Proquitté H; Wauer RR; Schmalisch G
J Crit Care; 2004 Mar; 19(1):42-7. PubMed ID: 15101005
[TBL] [Abstract][Full Text] [Related]
49. Visualization of inflammation using (19) F-magnetic resonance imaging and perfluorocarbons.
Stoll G; Basse-Lüsebrink T; Weise G; Jakob P
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(4):438-47. PubMed ID: 22422659
[TBL] [Abstract][Full Text] [Related]
50. Screening for Optimal Liposome Preparation Conditions by Using Dual Centrifugation and Time-Resolved Fluorescence Measurements.
Koehler JK; Schnur J; Heerklotz H; Massing U
Pharmaceutics; 2021 Nov; 13(12):. PubMed ID: 34959327
[TBL] [Abstract][Full Text] [Related]
51. Nanoemulsion contrast agents with sub-picomolar sensitivity for xenon NMR.
Stevens TK; Ramirez RM; Pines A
J Am Chem Soc; 2013 Jul; 135(26):9576-9. PubMed ID: 23742228
[TBL] [Abstract][Full Text] [Related]
52. Size-isolation of ultrasound-mediated phase change perfluorocarbon droplets using differential centrifugation.
Mercado KP; Radhakrishnan K; Stewart K; Snider L; Ryan D; Haworth KJ
J Acoust Soc Am; 2016 May; 139(5):EL142. PubMed ID: 27250199
[TBL] [Abstract][Full Text] [Related]
53. Polymeric perfluorocarbon nanoemulsions are ultrasound-activated wireless drug infusion catheters.
Zhong Q; Yoon BC; Aryal M; Wang JB; Ilovitsh T; Baikoghli MA; Hosseini-Nassab N; Karthik A; Cheng RH; Ferrara KW; Airan RD
Biomaterials; 2019 Jun; 206():73-86. PubMed ID: 30953907
[TBL] [Abstract][Full Text] [Related]
54. A stable, highly concentrated fluorous nanoemulsion formulation for in vivo cancer imaging via
Heaton AR; Lechuga LM; Tangsangasaksri M; Ludwig KD; Fain SB; Mecozzi S
NMR Biomed; 2024 May; 37(5):e5100. PubMed ID: 38230415
[TBL] [Abstract][Full Text] [Related]
55. Folate receptor-targeted
Xu X; Yan Y; Liu F; Wu L; Shao M; Wang K; Sun X; Li Y; Beinpuo ESW; Shen B
J Magn Reson Imaging; 2018 Dec; 48(6):1617-1625. PubMed ID: 29756310
[TBL] [Abstract][Full Text] [Related]
56. Polarographic cerebral oxygen availability, fluorocarbon blood levels and efficacy of oxygen transport by emulsions.
Clark LC; Spokane RB; Hoffmann RE; Sudan R; Homan MM; Maloney AC; Jacobs SJ; Stroup TL; Winston PE
Biomater Artif Cells Artif Organs; 1988; 16(1-3):375-93. PubMed ID: 3140920
[TBL] [Abstract][Full Text] [Related]
57. Phospholipid complex based nanoemulsion system for oral insulin delivery: preparation, in vitro, and in vivo evaluations.
Hu XB; Tang TT; Li YJ; Wu JY; Wang JM; Liu XY; Xiang DX
Int J Nanomedicine; 2019; 14():3055-3067. PubMed ID: 31118622
[No Abstract] [Full Text] [Related]
58. Nanoemulsions for delivery of flavonoids: formulation and in vitro release of rutin as model drug.
Macedo AS; Quelhas S; Silva AM; Souto EB
Pharm Dev Technol; 2014 Sep; 19(6):677-80. PubMed ID: 23930932
[TBL] [Abstract][Full Text] [Related]
59. Optimization and characterization of the formation of oil-in-water diazinon nanoemulsions: Modeling and influence of the oil phase, surfactant and sonication.
Badawy MEI; Saad ASA; Tayeb EHM; Mohammed SA; Abd-Elnabi AD
J Environ Sci Health B; 2017 Dec; 52(12):896-911. PubMed ID: 29111904
[TBL] [Abstract][Full Text] [Related]
60. Redox-Responsive Gene Delivery from Perfluorocarbon Nanoemulsions through Cleavable Poly(2-oxazoline) Surfactants.
Estabrook DA; Day RA; Sletten EM
Angew Chem Int Ed Engl; 2021 Aug; 60(32):17362-17367. PubMed ID: 33930255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
